Сlinical cases of newly diagnosed systemic lupus erythematosus at the appointment with a dermatologist

Abstract

Lupus erythematosus is a multisystemic connective tissue disease that has a wide range of manifestations affecting the skin and mucous membranes, joints, kidneys, heart, lungs, and central nervous system. In dermatology, cutaneous forms of lupus erythematosus can be classified into discoid, disseminated, centrifugal erythema, lupus panniculitis, subacute and chronic lupus, and systemic lupus erythematosus with damage to internal organs. It can develop as an independent disease or can be a result of progression of cutaneous forms.

The skin is the second most commonly affected organ in systemic lupus erythematosus folowing the joints, with skin manifestations observed in 80% of patients throughout the course of the disease. And in 20−30% of cases, the disease debuts with skin rash. Thus, these patients primarily present to dermatologists. Knowledge of the criteria for making a diagnosis, the clinical characteristics, in combination with performance of advanced laboratory diagnostic tests allow a dermatologist to suspect a systemic process in a timely manner and prescribe appropriate therapy.

The article presents two clinical observations of male patients with systemic lupus erythematosus, the diagnosis of which could not have been established for several years. The diagnosis in these cases met the 2019 European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus, confirmed by laboratory tests. Patients had a positive trend to response to therapy.

Keywords

lupus erythematosus / systemic lupus erythematosus / cutaneus lupus erythematosus

References

[1] Kang S, Amadai M, Bruckner AL, et al. Fitzpatrick’s dermatology. 9th ed. Vol. 1. McGraw-Hill Education; 2019. Р. 1037−1039.

[2] Kang S., Amadai M., Bruckner A.L., et al. Fitzpatrick’s dermatology. 9th ed. Vol. 1. McGraw-Hill Education, 2019. P. 1037−1039.

[3] Olisova OY. Skin and venereal diseases. Moscow: Practical Medicine; 2015. Р. 186–192. (In Russ).

[4] Олисова О.Ю. Кожные и венерические болезни. Москва: Практическая медицина, 2015. С. 186−192.

[5] Tlish MM, Naatyzh ZY, Sycheva NL, et al. Systemic lupus erythematosus: an interdisciplinary approach to the diagnosis. Russ J Skin Venereal Diseases. 2016;19(3):141−147. (In Russ). doi: 10.18821/1560-9588-2016-19-3-141-147

[6] Тлиш М.М., Наатыж Ж.Ю., Сычева Н.Л., и др. Системная красная волчанка: междисциплинарный подход к диагностике // Российский журнал кожных и венерических болезней. 2016. Т. 19, № 3. С. 141−147. doi: 10.18821/1560-9588-2016-19-3-141-147

[7] Kubanov AA, Samtsov AV, Khayrutdinov VR, et al. Clinical guidelines. Lupus erythematosus. All-Russian Public Organization Russian Society of Dermatovenereologists and Cosmetologists; 2020. Р. 6–17. (In Russ).

[8] Кубанов А.А., Самцов А.В., Хайрутдинов В.Р., и др. Клинические рекомендации. Красная волчанка. Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», 2020. C. 6–17.

[9] Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus. 1997;6(2):96−104. doi: 10.1177/096120339700600204

[10] Tebbe B., Orfanos C.E. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus // Lupus. 1997. Vol. 6, N 2. Р. 96−104. doi: 10.1177/096120339700600204

[11] Trofimov PN, Antonova OV, Shvyrev DN, et al. Cutaneous lupus erythematosus: pathogenesis, clinical pattern, diagnostics, therapy. Bulletin Dermatol Venereol. 2015;91(5):24−33. (In Russ). doi: 10.25208/0042-4609-2015-91-5-24-33

[12] Трофимов П.Н., Антонова О.В., Швырев Д.Н., и др. Кожные формы красной волчанки: патогенез, клиника, диагностика, терапия // Вестник дерматологии и венерологии. 2015. Т. 91. № 5. C. 24−33. doi: 10.25208/0042-4609-2015-91-5-24-33

[13] Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050−1070. doi: 10.1177/0961203310370048

[14] Obermoser G., Sontheimer R.D., Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates // Lupus. 2010. Vol. 19, N 9. Р. 1050−1070. doi: 10.1177/0961203310370048

[15] Ackermann AB. Lupus erythematosus. In: Histologic diagnosis of inflammatory skin diseases. Baltimore: Williams & Wilkins; 1997. Р. 525−546.

[16] Ackermann A.B. Lupus erythematosus. In: Histologic diagnosis of inflammatory skin diseases. Baltimore: Williams & Wilkins, 1997. Р. 525−546.

[17] Alekseeva EI, Dvoryakovskaya TM, Nikishina IP, et al. Systemic lupus erythematosus: clinical recommendations. Part 1. Questions Modern Pediatrics. 2018;17(1):19–37. (In Russ). doi: 10.15690/vsp.v17i1.1853

[18] Алексеева Е.И., Дворяковская Т.М., Никишина И.П., и др. Системная красная волчанка: клинические рекомендации. Часть 1 // Вопросы современной педиатрии. 2018. Т. 17, № 1. С. 19–37. doi: 10.15690/vsp.v17i1.1853

[19] Alekseeva EI, Dvoryakovskaya TM, Nikishina IP, et al. Systemic lupus erythematosus: clinical recommendations. Part 2. Questions Modern Pediatrics. 2018;17(2):110–125. (In Russ). doi: 10.15690/vsp.v17i2.1877

[20] Алексеева Е.И., Дворяковская Т.М., Никишина И.П., и др. Системная красная волчанка: клинические рекомендации. Часть 2 // Вопросы современной педиатрии. 2018. Т. 17, № 2. С. 110–125. doi: 10.15690/vsp.v17i2.1877

[21] Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism / American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400−1412. doi: 10.1002/art.40930

[22] Aringer M., Costenbader K., Daikh D., et al. 2019 European league against rheumatism / American college of rheumatology classification criteria for systemic lupus erythematosus // Arthritis Rheumatol. 2019. Vol. 71, N 9. Р. 1400−1412. doi: 10.1002/art.40930

[23] Andrade RM, Alarcón GS, Fernández M, et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007;56(2):622−630. doi: 10.1002/art.22375

[24] Andrade R.M., Alarcón G.S., Fernández M., et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort // Arthritis Rheum. 2007. Vol. 56, N 2. Р. 622−630. doi: 10.1002/art.22375

[25] Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736−745. doi: 10.1136/annrheumdis-2019-215089

[26] Fanouriakis A., Kostopoulou M., Alunno A., et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus // Ann Rheum Dis. 2019. Vol. 78, N 6. Р. 736−745. doi: 10.1136/annrheumdis-2019-215089

[27] Lebedeva S, Teplyuk N, Belousova T, et al. Possibilities of external therapy of discoid red. Doctor. 2015;(2):49−51. (In Russ).

[28] Лебедева С., Теплюк Н., Белоусова Т., и др. Возможности наружной терапии дискоидной красной волчанки // Врач. 2015. № 2. С. 49−51.

[29] Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050−1070. doi: 10.1177/0961203310370048

[30] Obermoser G., Sontheimer R.D., Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates // Lupus. 2010. Vol. 19, N 9. Р. 1050−1070. doi: 10.1177/0961203310370048

[31] Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24(5):348−362. doi: 10.1016/j.clindermatol.2006.07.014

[32] Rothfield N., Sontheimer R.D., Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations // Clin Dermatol. 2006. Vol. 24, N 5. Р. 348−362. doi: 10.1016/j.clindermatol.2006.07.014

[33] Ribero S, Sciascia S, Borradori L, Lipsker D. The cutaneous spectrum of lupus erythematosus. Clin Rev Allergy Immunol. 2017;53(3):291−305. doi: 10.1007/s12016-017-8627-2

[34] Ribero S., Sciascia S., Borradori L., et al. The cutaneous spectrum of lupus erythematosus // Clin Rev Allergy Immunol. 2017. Vol. 53, N 3. Р. 291−305. doi: 10.1007/s12016-017-8627-2

[35] Durosaro O, Davis MD, Reed KB, et al. Incidence of cutaneous lupus erythematosus, 1965−2005: a population-based study. Arch Dermatol. 2009;145(3):249−253. doi: 10.1001/archdermatol.2009.21

[36] Durosaro O., Davis M.D., Reed K.B., et al. Incidence of cutaneous lupus erythematosus, 1965−2005: a population-based study // Arch Dermatol. 2009. Vol. 145, N 3. Р. 249−253. doi: 10.1001/archdermatol.2009.21

[37] Tlish MM, Naatyzh ZY, Sycheva NL, et al. Difficulties in the diagnosis of systemic lupus erythematosus. Russ J Skin Venereal Diseases. 2014;(3):36−41. (In Russ).

[38] Тлиш М.М., Наатыж Ж.Ю., Сычева Н.Л., и др. Трудности диагностики системной красной волчанки // Российский журнал кожных и венерических болезней. 2014. № 3. С. 36−41.

RIGHTS & PERMISSIONS

Morozova E.A., Bausheva E.A.